# Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

> **NCT00004173** · PHASE1 · UNKNOWN · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00004173
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004173, "Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*